JNJ
Johnson & Johnson$253.97-1.76% 1D· price as of Jun 30, 8:32 PM+67.07% over 1Y
Compare:JNJ
Mkt Cap
$611.4B
P/E
29.4×
Fwd P/E
20.0×
PEG
4.89
P/B
7.5×
P/S
6.3×
EV/EBITDA
18.8×
Beta
0.26
Div Yield
2.1%
Payout
60.3%
ROE
26.4%
Net Margin
21.8%
Short % Flt
1.1%
Inst. Own
76.9%
52-wk low $152.81$253.9752-wk high $259.88
+66.2% above low-2.3% from high
Seasonality — avg monthly return
Strongest Jul 4.0% · weakest Apr -2.3%Jan
+2.2
Feb
+1.0
Mar
+1.6
Apr
-2.3
May
-0.5
Jun
+2.6
Jul
+4.0
Aug
+0.4
Sep
-1.4
Oct
+0.6
Nov
+1.8
Dec
+0.7
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Johnson & Johnson
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
JNJ — recent news
Loading headlines…
Quality scorecard
vs Pharmaceuticals · 7 peers · percentile rank
33 / 100
Below average
ROIC16.3%
33
ROE32.9%
33
Gross margin67.9%
17
Operating margin27.2%
17
FCF yield3.2%
17
Net debt / EBITDA0.7×
83
Percentile vs 7 Pharmaceuticals peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.